Par Drugs and Chemicals Limited (NSE:PAR)

India flag India · Delayed Price · Currency is INR
92.00
+1.83 (2.03%)
Mar 10, 2026, 10:23 AM IST
-10.20%
Market Cap 1.11B
Revenue (ttm) 1.06B
Net Income (ttm) 139.06M
Shares Out 12.30M
EPS (ttm) 11.31
PE Ratio 7.98
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 2,053
Average Volume 10,523
Open 95.48
Previous Close 90.17
Day's Range 91.31 - 95.48
52-Week Range 81.01 - 122.43
Beta -0.41
RSI 41.36
Earnings Date Feb 10, 2026

About Par Drugs and Chemicals

Par Drugs and Chemicals Limited develops, manufactures, and sells active pharmaceutical ingredients (APIs) and fine chemicals in India. The company provides API products, including magnesium hydroxide, magnesium oxide USP, sucralfate, almagate BP, dried aluminium hydroxide gel, light magnesium carbonate, magaldrate, magnesium trisilicate, colloidal silicon dioxide, aluminium magnesium silicate, magnesium aluminometasilicate, magnesium aluminosilicate-USP, magnesium oxide light, magnesium oxide heavy, magnesium aluminium hydrate, hydrotalcite, a... [Read more]

Sector Healthcare
Founded 1982
Employees 121
Stock Exchange National Stock Exchange of India
Ticker Symbol PAR
Full Company Profile

Financial Performance

In fiscal year 2025, Par Drugs and Chemicals's revenue was 1.01 billion, an increase of 5.58% compared to the previous year's 956.40 million. Earnings were 133.58 million, a decrease of -7.88%.

Financial Statements

News

There is no news available yet.